We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
+6.91%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$197B
AUM Growth
+$30.1B
Cap. Flow
+$20.8B
Cap. Flow %
10.56%
Top 10 Hldgs %
18.65%
Holding
7,926
New
1,213
Increased
2,561
Reduced
2,476
Closed
1,232

Sector Composition

Rank Sector Weight
1 Technology 7.9%
2 Financials 6.62%
3 Healthcare 6.1%
4 Consumer Discretionary 4.86%
5 Industrials 4.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SABSW icon
6151
CALL
SAB Biotherapeutics Warrant
SABSW
$158K
$112K ﹤0.01%
62,500
ATOS icon
6152
Atossa Therapeutics
ATOS
$20.6M
$111K ﹤0.01%
4,616
-12,985
-74% -$475K
BRIVW
6153
CALL
DELISTED
B. Riley Principal 250 Merger Corp. Warrant
BRIVW
$111K ﹤0.01%
138,335
FSNB.WS
6154
CALL
DELISTED
Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
FSNB.WS
$111K ﹤0.01%
185,417
-166,905
-47% -$116K
ISPOW
6155
CALL
DELISTED
Inspirato Inc Warrant
ISPOW
$110K ﹤0.01%
112,500
CAMP
6156
DELISTED
CalAmp Corp.
CAMP
$110K ﹤0.01%
679
-1,190
-64% -$264K
CPTK
6157
CALL
DELISTED
Crown PropTech Acquisitions
CPTK
$110K ﹤0.01%
193,854
-57,955
-23% -$570K
BTMDW
6158
CALL
DELISTED
Biote Corp. Warrant
BTMDW
$110K ﹤0.01%
152,777
-56,128
-27% -$45.3K
FRSGU
6159
DELISTED
First Reserve Sustainable Growth Corp. Unit
FRSGU
$110K ﹤0.01%
10,000
-90,000
-90% -$921K
MDH.WS
6160
CALL
DELISTED
MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
MDH.WS
$110K ﹤0.01%
239,437
-40,562
-14% -$24K
CDTX
6161
DELISTED
Cidara Therapeutics
CDTX
$109K ﹤0.01%
4,289
-11,618
-73% -$362K
AUGX
6162
DELISTED
Augmedix, Inc. Common Stock
AUGX
$109K ﹤0.01%
+34,651
New +$126K
USWS
6163
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
$109K ﹤0.01%
+15,850
New +$194K
FVT.WS
6164
CALL
DELISTED
Fortress Value Acquisition Corp. III Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
FVT.WS
$109K ﹤0.01%
138,471
-35,560
-20% -$34.1K
PLM
6165
DELISTED
PolyMet Mining Corp.
PLM
$109K ﹤0.01%
43,501
+21,507
+98% +$65.5K
SACH
6166
Sachem Capital Corp
SACH
$39.1M
$108K ﹤0.01%
+18,507
New +$107K
ELUT icon
6167
Elutia
ELUT
$37.9M
$107K ﹤0.01%
17,062
-11,488
-40% -$67.3K
VRNA
6168
DELISTED
Verona Pharma
VRNA
$107K ﹤0.01%
15,969
+1,183
+8% +$6.04K
SLACW
6169
CALL
DELISTED
Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SLACW
$107K ﹤0.01%
128,557
+40,738
+46% +$34.9K
KSICU
6170
DELISTED
Kadem Sustainable Impact Corporation Unit
KSICU
$107K ﹤0.01%
10,681
-2,069
-16% -$20.7K
HIPO.WS
6171
CALL
DELISTED
Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share
HIPO.WS
$106K ﹤0.01%
220,934
-225,700
-51% -$156K
SURF
6172
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$106K ﹤0.01%
22,192
-52,412
-70% -$338K
GAPA.WS
6173
CALL
DELISTED
G&P Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
GAPA.WS
$106K ﹤0.01%
194,375
GNE icon
6174
Genie Energy
GNE
$367M
$105K ﹤0.01%
+18,892
New +$104K
MKTW icon
6175
MarketWise
MKTW
$52.5M
$105K ﹤0.01%
699
-154
-18% -$21.9K

Similar funds

Millennium Management's Q4 2021 Portfolio in Review

As of Q4 2021, Millennium Management held 7,926 positions worth $197B, up 18% from $167B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Millennium Management deployed $20.8B of net new capital in Q4 2021, opening 1,213 new positions and adding to 2,561 existing holdings. Its largest new stake was Comcast: 3,028,627 shares worth $152M.

By sector, the portfolio is most concentrated in Technology at 7.9% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street Technology Select Sector SPDR ETF, an estimated $291M trimmed.

  • Millennium Management's largest Q4 2021 buy was Comcast: 3,028,627 shares worth $152M.
  • Millennium Management added most to iShares Core S&P 500 ETF in Q4 2021, an estimated $1.38B increase.
  • Millennium Management's biggest Q4 2021 reduction was State Street Technology Select Sector SPDR ETF, cutting an estimated $291M.
  • Millennium Management fully exited Kansas City Southern in Q4 2021, selling an estimated $227M.
  • Millennium Management's ten largest holdings make up 19% of its $197B portfolio in Q4 2021.
  • Millennium Management opened 1,213 new positions and closed 1,232 in Q4 2021.
  • Millennium Management's portfolio value rose 18% quarter-over-quarter to $197B.

Based on Millennium Management's 13F filing for Q4 2021, filed 14 Feb 2022.